C-reactive protein but not hepcidin, NGAL and transferrin determines the ESA resistance in hemodialysis patients.

about

Proteogenomic studies on cancer drug resistance: towards biomarker discovery and target identification.Epoetin alfa resistance in hemodialysis patients with chronic kidney disease: a longitudinal study.

P2860

Q38918710-945E4078-9CFF-46A3-91A5-B5282A3E54AA Q55274440-B1D0192A-95C2-49EC-8AFE-4E32EE3A3AD8

P2860

C-reactive protein but not hepcidin, NGAL and transferrin determines the ESA resistance in hemodialysis patients.

Item

http://www.wikidata.org/entity/Q53810360

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

C-reactive protein but not hep ...... ance in hemodialysis patients.

@en

C-reactive protein but not hep ...... ance in hemodialysis patients.

@nl

type

Item

label

C-reactive protein but not hep ...... ance in hemodialysis patients.

@en

C-reactive protein but not hep ...... ance in hemodialysis patients.

@nl

prefLabel

C-reactive protein but not hep ...... ance in hemodialysis patients.

@en

C-reactive protein but not hep ...... ance in hemodialysis patients.

@nl

P1476

C-reactive protein but not hep ...... ance in hemodialysis patients.

@en

P2093

Abdullah Ozkok

http://www.w3.org/2001/XMLSchema#string

Ahmet Kolukısa

http://www.w3.org/2001/XMLSchema#string

Ali Rıza Odabaş

http://www.w3.org/2001/XMLSchema#string

Banu Işbilen Başok

http://www.w3.org/2001/XMLSchema#string

Ferruh Kemal Işman

http://www.w3.org/2001/XMLSchema#string

Ibrahim Yılmaz

http://www.w3.org/2001/XMLSchema#string

Ilyas Duran

http://www.w3.org/2001/XMLSchema#string

Osman Kostek

http://www.w3.org/2001/XMLSchema#string

P2860

Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization

Hepcidin and iron homeostasis

The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition

An iron delivery pathway mediated by a lipocalin

Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease

Hepcidin-25 in chronic hemodialysis patients is related to residual kidney function and not to treatment with erythropoiesis stimulating agents

Disturbances of acquired immunity in hemodialysis patients.

Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents.

Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease/chronic heart failure patients.

Early detection and intervention using neutrophil gelatinase-associated lipocalin (NGAL) may improve renal outcome of acute contrast media induced nephropathy: a randomized controlled trial in patients undergoing intra-arterial angiography (ANTI-CIN

P304

89-95

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/0886022X.2015.1106896

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26539647

http://www.w3.org/2001/XMLSchema#string

C-reactive protein but not hepcidin, NGAL and transferrin determines the ESA resistance in hemodialysis patients.

about

P2860

P2860

C-reactive protein but not hepcidin, NGAL and transferrin determines the ESA resistance in hemodialysis patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698